Application

17814224 · HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS

Filed 2022-07-21 · Abandoned The official file ↗ · Art unit 1624 · Examiner Susanna Moore Typical · CPC A61K 31/437 · Millennium Pharmaceuticals, Inc. · Viracta Therapeutics, Inc

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

8.1 mo

to disposition 22.8 mo

Statutes raised

102 103 112

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.